The COVID-19 pandemic has created numerous challenges for healthcare services globally and as part of Gilead’s commitment to facilitate discussions around viral hepatitis screening and linkage to care, the annual face-to-face SLTC Summit meeting went fully digital in July 2020.

The resulting SLTC Summit virtual series saw the development of 12 exclusive interviews with key stakeholders, two unique discussion-only webinars, six webinars focussed on exploring good practice within different settings, 17 models of care developed into infographics and an interactive map comprising over 100 examples of good practice from around the world delivered over a six month period. Almost 40 expert faculty from 17 countries, representing key stakeholders in hepatitis care – including hepatologists, nurses and patient advocacy groups – shared their personal insights into the management of patients with viral hepatitis in today’s. In-keeping with the dramatic changes to healthcare systems, 2020’s SLTC Summit has truly been one of a kind!

Explore the SLTC Summit pages to find all these materials and more, and be sure to keep an eye out for the 2021 SLTC Summit activities – coming soon!

SLTC Summit Visual Summary

They say that a picture can say a thousand words and, since inception, we have tried to capture the breadth of discussions that takes place at the SLTC Summit in the form of a visual summary.
Expertly drawn by a visual artist, the SLTC Summit 2020 Visual Summaries can be accessed below:

 

SLTC Full Poster

SLTC: Where are we now?

Telemedicine and COVID-19

Correctional settings

Harm reduction settings

Mobile/Outreach settings

Drug treatment settings

Community/Primary care settings

Keep up to date with regular SLTC Summit communications

  • By registering your attendance and pressing “Submit”, you acknowledge that Gilead Sciences Europe Ltd (together with its affiliates subsidiaries, "Gilead”) and Gilead's agents (Elements Communications Ltd, AVT and Optimum4 Ltd,) will process the personal information provided by you at the time of registration for the purpose of recording your attendance at the meeting, contacting you regarding the meeting and sending you post-meeting materials. Your details may be shared with the Gilead affiliate in your country and outside of the EU. For further information on how Gilead handles personal information please refer to the Gilead Privacy Statement, available at: www.gilead.com/privacy

Good practice webinar on Drug treatment settings

Ondemand webinar now available

Following the live SLTC Summit good practice webinar, we are pleased to announce that the on-demand webinar is now available.

Alain Litwin was joined by three faculty members, where they shared their experiences, insights and models of care on drug treatment settings as they looked to define good practice screening and linkage to care for people with viral hepatitis.

Watch the webinar on demand now

Good practice webinar on Community and Primary care settings

Ondemand webinar now available

Following the live SLTC Summit good practice webinar, we are pleased to announce that the on-demand webinar is now available.

Gonçalo Lobo was joined by three faculty members, where they shared their experiences, insights and models of care on community and primary care settings as they looked to define good practice screening and linkage to care for people with viral hepatitis.

Watch the webinar on demand now


Watch the webinars on-demand

 

SLTC 2020: where are we now? Morning session

 

SLTC 2020: where are we now? Afternoon session

 

Telemedicine and COVID-19

 

Correctional settings

 

Harm reduction

 

Outreach / mobile settings

 

Drug treatment settings

 

Community and Primary care settings

The history of the SLTC Summit

All people involved in the care and well-being of people affected by hepatitis C should have a seat at the table when viral hepatitis screening and linkage to care is being discussed. This has been the central concept of the SLTC Summit since its inauguration in 2017. Peer workers to policy makers. Hepatologists, infectious disease physicians, addiction specialists, nurses, pharmacists, general practitioners, epidemiologists, microbiologists, social workers, and more – all are welcome. Every voice, every perspective, is important.

Since inception, the format and topics of discussion at the SLTC Summit have been ratified and fine-tuned in collaboration with a steering committee of global experts. The inaugural meeting in 2017, ‘Bridging the gaps for people who inject drugs’, focussed on addressing barriers to linking people who inject drugs with hepatitis C care. In 2018, ‘Transforming the HCV care cascade for people who use drugs – inspired by possibilities’, we expanded focus to a broader population of people who use drugs and those in the prison setting. Most recently, in 2019, ‘Exploring new frontiers in HCV care’, we expanded once more to discuss how we could ensure that all under-served populations received the hepatitis C care they deserved and, together, accelerate the journey towards the ultimate goal of HCV elimination.

2017 SLTC Summit Invitation

2018 SLTC Summit Invitation

2019 SLTC Summit Invitation

Screening and Linkage to Care and COVID-19

The COVID-19 pandemic has had a considerable impact on viral hepatitis screening and linkage to care across the globe, we teamed up with 10 experts to find out more about how care has evolved globally. Find out more here

There are many examples of good practice initiatives which are enhancing progress towards viral hepatitis elimination, find out more about some of these initiatives here.

The annual SLTC Summit is well known for bringing all stakeholders together by providing a platform for colleagues and peers from around the world to connect and share insights. As we embark on a digital format for this year, it's more important now than ever before to keep the conversations going! To hear more from the experts, click below.

IHQ-HCV-2020-09-0023 • Date of preparation: February 2021